Skip to main content
. 2015 Dec 15;5:18160. doi: 10.1038/srep18160

Table 2. Prevalence of FEN1 genotype frequencies and gallbladder cancer risk by gallbladder stone.

  FEN1 genotype Controls n(%) Cases n(%) Crude OR 95% CI) Adjusted ORa (95% CI) Trend test (P value)b
Total C.-69G > A          
  AA 70 (20.6) 38 (11.1)c 1.0 (reference) 1.0 (reference) P < 0.001
  GA 160 (47.2) 164 (48.1) 1.73 (1.02–2.63) 1.74 (1.02–2.64)  
  GG 109 (32.2) 139 (40.8) 2.29 (1.31–3.95) 2.31 (1.32–3.96)  
Sex
 Male AA 22 (20.8) 12 (11.1) 1.0 (reference) 1.0 (reference) P < 0.001
  GA 50 (47.2) 51 (47.3) 1.75 (1.03–2.65) 1.76 (1.04–2.66)  
  GG 34 (32.0) 45 (42.6) 2.42 (1.32–4.96) 2.43 (1.35–4.98)  
 Female AA 48 (20.6) 26 (11.2) 1.0 (reference) 1.0 (reference) P < 0.004
  GA 110 (47.2) 113 (48.5) 1.63 (1.01–2.58) 1.64 (1.02–2.59)  
  GG 75 (32.2) 94 (40.3) 2.18 (1.29–3.37) 2.19 (1.30–3.38)  
Gallstone status
 Absence AA 67 (21.1) 30 (20.8) 1.0 (reference) 1.0 (reference) P = 0.81
  GA 145 (45.6) 66 (45.8) 1.1 (0.3–3.0) 1.1 (0.3–3.1)  
  GG 106 (33.3) 48 (33.3) 1.2 (0.4–3.2) 1.3 (0.4–3.3)  
 Presence AA 3 (14.3) 8 (4.1) 1.0 (reference) 1.0 (reference) P < 0.001
  GA 15 (71.4) 98 (49.7) 2.2 (1.4–3.4) 2.3(1.5–3.5)  
  GG 3 (14.3) 91 (46.2) 5.9 (1.8–18.6) 6.8 (2.1–28.3)  
Size of largest gallstone
 <2 cm AA 3 (33.3) 3 (3.6) 1.0 (reference) 1.0 (reference) P < 0.001
  GA 6 (66.7) 57 (68.7) 1.9 (0.7–3.8) 2.0 (0.7–3.9)  
  GG 0 (0) 23 (27.7) 3.4 (1.6–16.2) 3.5 (1.7–17.2)  
 ≥2 cm AA 0 (0) 5 (4.4) 1.0 (reference) 1.0 (reference) P < 0.001
  GA 9 (75.0) 41 (36.0) 2.0 (0.9–4.2) 2.1 (1.0–4.5)  
  GG 3 (25.0) 68 (59.6) 7.2 (1.7–18.6) 7.3 (1.8–18.8)  
Total C.4150G > T          
  TT 74 (21.8) 44 (12.9)d 1.0 (reference) 1.0 (reference) P < 0.001
  GT 167 (49.3) 166 (48.4) 1.93 (1.04–2.91) 1.95 (1.09–2.94)  
  GG 98 (28.9) 131 (38.7) 2.56 (1.37–5.39) 2.57 (1.39–5.52)  
Sex
 Male TT 23 (21.7) 14 (13.0) 1.0 (reference) 1.0 (reference) P < 0.001
  GT 52 (49.1) 52 (48.1) 1.59 (1.01–2.32) 1.60 (1.02–2.33)  
  GG 31 (29.2) 42 (38.9) 2.43 (1.31–3.42) 2.44 (1.32–3.43)  
 Female TT 51 (21.9) 30 (12.5) 1.0 (reference) 1.0 (reference) χ2 < 0.001
  GT 114 (48.9) 114 (48.9) 1.71 (1.01–2.62) 1.72 (1.02–2.63)  
  GG 68 (29.2) 89 (38.6) 2.16 (1.22–4.91) 2.17 (1.23–4.92)  
Gallstone status
 Absence TT 69 (21.8) 29 (20.1) 1.0 (reference) 1.0 (reference) P = 0.89
  GT 152 (47.8) 68 (47.2) 1.2 (0.4–3.1) 1.3 (0.5–3.2)  
  GG 97 (30.4) 47 (32.6) 1.3 (0.5–3.8) 1.4 (0.6–3.9)  
 Presence TT 3 (14.3) 15 (7.6) 1.0 (reference) 1.0 (reference) P < 0.001
  GT 15 (71.4) 98 (49.7) 3.6 (1.4–9.6) 3.7 (1.4–9.8)  
  GG 3 (14.3) 84 (42.6) 7.1 (2.1–20.1) 7.2 (2.2–20.2)  
Size of largest gallstone
 <2 cm TT 3 (33.3) 3 (3.6) 1.0 (reference) 1.0 (reference) P < 0.001
  GT 6 (66.7) 55 (66.3) 2.1 (0.8–4.2) 2.2 (0.8–4.3)  
  GG 0 (0) 25 (30.1 5.4 (1.2–16.6) 5.5 (1.3–16.7)  
 ≥2 cm TT 0 (0) 12 (10.5) 1.0 (reference) 1.0 (reference) P < 0.001
  GT 9 (75.0) 43 (37.7) 2.2 (0.9–4.8) 2.3 (1.0–4.9)  
  GG 3 (25.0) 59 (51.8) 8.1 (1.4–19.4) 8.2 (1.5–19.8)  

aAdjusted for age, sex and gallstone.

bTrend test assessing correlation between gallbladder cancer risk and predicting high risk FEN1 genotypes.

cNumbers in parenthesis refer to percentages.

dNumbers in parenthesis refer to percentages.